135 related articles for article (PubMed ID: 9894245)
1. Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer.
Günther T; Schneider-Stock R; Pross M; Manger T; Malfertheiner P; Lippert H; Roessner A
Pathol Res Pract; 1998; 194(12):809-13. PubMed ID: 9894245
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
[TBL] [Abstract][Full Text] [Related]
6. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer.
Ficorella C; Cannita K; Ricevuto E; Toniato E; Fusco C; Sinopoli NT; De Galitiis F; Di Rocco ZC; Porzio G; Frati L; Gulino A; Martinotti S; Marchetti P
Oncol Rep; 2003; 10(1):169-73. PubMed ID: 12469165
[TBL] [Abstract][Full Text] [Related]
7. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
[TBL] [Abstract][Full Text] [Related]
9. Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors.
Schneider-Stock R; Walter H; Haeckel C; Radig K; Rys J; Roessner A
Int J Oncol; 1998 Aug; 13(2):325-9. PubMed ID: 9664128
[TBL] [Abstract][Full Text] [Related]
10. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
11. p300 gene alterations in intestinal and diffuse types of gastric carcinoma.
Koshiishi N; Chong JM; Fukasawa T; Ikeno R; Hayashi Y; Funata N; Nagai H; Miyaki M; Matsumoto Y; Fukayama M
Gastric Cancer; 2004; 7(2):85-90. PubMed ID: 15224194
[TBL] [Abstract][Full Text] [Related]
12. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.
Ryan A; Al-Jehani RM; Mulligan KT; Jacobs IJ
Gynecol Oncol; 1998 Jan; 68(1):14-7. PubMed ID: 9454653
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
14. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of the ATBF1 gene in gastric cancer.
Cho YG; Song JH; Kim CJ; Lee YS; Kim SY; Nam SW; Lee JY; Park WS
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4355-9. PubMed ID: 17671116
[TBL] [Abstract][Full Text] [Related]
17. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53.
Yoshimura A; Sugihara H; Ling ZQ; Peng DF; Mukaisho K; Fujiyama Y; Hattori T
Pathobiology; 2006; 73(1):40-9. PubMed ID: 16785766
[TBL] [Abstract][Full Text] [Related]
18. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
19. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
[TBL] [Abstract][Full Text] [Related]
20. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]